SCHEMBL3657481

SCHEMBL3657481

CC[C@@]1(C)CCCC[C@@H]1C

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.31
SLC6A4 P31645 2/20 0.30
SLC6A3 Q01959 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17800120 1.00 GAA (0.31) GAASLC6A4SLC6A3
SCHEMBL6703558 1.00 GAA (0.31) GAASLC6A4SLC6A3
SCHEMBL2449769 0.98 GAA (0.31) GAA
SCHEMBL2345264 0.93
SCHEMBL9787725 0.83 SLC6A4 (0.31) SLC6A4SLC6A3
SCHEMBL1692296 0.82
SCHEMBL27449789 0.80 SLC6A4 (0.34) SLC6A4SLC6A3
SCHEMBL24329981 0.79 GAA (0.31) GAA
SCHEMBL5245937 0.79 CDC25A (0.35)
SCHEMBL11903723 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2203163-A1 TITRATION PACKAGE FOR NERAMEXANE AND ITS USE IN THE TREATMENT OF AN INNER EAR DISORDER Merz Pharma GmbH & Co. KGaA (DE) 2010-07-07 EP disclosed
WO-2009033651-A1 TITRATION PACKAGE FOR NERAMEXANE AND ITS USE IN THE TREATMENT OF AN INNER EAR DISORDER MERZ PHARMA GMBH & CO. KGAA (DE) 2009-03-19 WO disclosed